)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Emergent BioSolutions
Emergent BioSolutions (EBS) investor relations material
Emergent BioSolutions Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary20 Mar, 2026
Voting matters and shareholder proposals
Election of four Class II directors for terms expiring at the 2029 Annual Meeting, with nominees Sujata Dayal, John Fowler, Jr., Zsolt Harsanyi, Ph.D., and Joseph Papa recommended for election.
Ratification of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory vote to approve 2025 compensation for named executive officers.
Approval sought for an amendment to the Amended and Restated Stock Incentive Plan to increase the number of shares available for awards.
Provision to transact other business as may properly come before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and all proposals presented.
Director terms for those elected will expire at the 2029 Annual Meeting.
Executive compensation and say-on-pay
Advisory vote scheduled to approve 2025 compensation for named executive officers.
Proposal includes an amendment to the stock incentive plan to increase available shares for grants.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Emergent BioSolutions
- Proxy covers director elections, auditor ratification, pay, and equity plan amendment.EBS
Proxy filing20 Mar 2026 - 2025 saw a profitable turnaround with $743M revenue, margin gains, and lower leverage.EBSQ4 202526 Feb 2026
- Q2 revenues beat guidance, but net loss widened; FY 2024 outlook and debt reduction targets raised.EBSQ2 20242 Feb 2026
- Revenue and EBITDA surged as Narcan and MCM products expand, fueling a strategic turnaround.EBSH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Q3 2024 net income hit $114.8M as revenue rose 9% and guidance was raised.EBSQ3 202416 Jan 2026
- Transformation boosts profitability, debt reduction, and innovation in biodefense and naloxone.EBS44th Annual J.P. Morgan Healthcare Conference15 Jan 2026
- Turnaround accelerates with debt cuts, asset sales, and expanded naloxone and MCM portfolios.EBS43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026
- Shelf registration enables up to $250M in flexible capital raising for growth and debt management.EBSRegistration Filing16 Dec 2025
- 2024 saw a turnaround with higher margins, lower debt, and strong Narcan leadership.EBSQ4 20242 Dec 2025
Next Emergent BioSolutions earnings date
Q1 20266 May, 2026
Emergent BioSolutions
Next Emergent BioSolutions earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage